Metabolic regulation of antibiotic resistance

FEMS Microbiology Reviews

Volumn 35, Issue 5, 2011, Pages 768-789

  Martínez, José L ^a   Rojo, Fernando ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Bacterial metabolism; Biofilm; Fitness cost; Global regulation; Persister; Signal transduction

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBON; CBRA PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; FOSFOMYCIN; IMIPENEM; ISONIAZID; METRONIDAZOLE; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN F; PENICILLIN BINDING PROTEIN; PENICILLIN G; POLYMYXIN; QUINOLONE DERIVATIVE; RNA BINDING PROTEIN; STREPTOMYCIN; TETRACYCLINE; TOBRAMYCIN; TUBERCULOSTATIC AGENT; TUNICAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL METABOLISM; BIOFILM; CARBON METABOLISM; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HUMAN; MEMBRANE PERMEABILITY; METABOLIC REGULATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; TUBERCULOSIS;

ADAPTATION, PHYSIOLOGICAL; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; METABOLIC NETWORKS AND PATHWAYS; STRESS, PHYSIOLOGICAL;

BACTERIA (MICROORGANISMS);

EID: 79960939536     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/j.1574-6976.2011.00282.x     Document Type: Review

References (235)

1. Abranches J, Martinez AR, Kajfasz JK, Chavez V, Garsin DA & Lemos JA (2009) The molecular alarmone (p)ppGpp mediates stress responses, vancomycin tolerance, and virulence in Enterococcus faecalis. J Bacteriol 191: 2248-2256.
2. Aendekerk S, Ghysels B, Cornelis P & Baysse C (2002) Characterization of a new efflux pump, MexGHI-OpmD, from Pseudomonas aeruginosa that confers resistance to vanadium. Microbiology 148: 2371-2381.
3. Aendekerk S, Diggle SP, Song Z, Hoiby N, Cornelis P, Williams P & Camara M (2005) The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication. Microbiology 151: 1113-1125.
4. Alekshun MN & Levy SB (1997) Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Ch 41: 2067-2075.
5. Alekshun MN & Levy SB (2007) Molecular mechanisms of antibacterial multidrug resistance. Cell 128: 1037-1050.
6. Allison KR, Brynildsen MP & Collins JJ (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473: 216-220.
7. Alonso A & Martinez JL (1997) Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob Agents Ch 41: 1140-1142.
8. Alonso A & Martinez JL (2000) Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Ch 44: 3079-3086.
9. Alonso A & Martinez JL (2001) Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrob Agents Ch 45: 1879-1881.
10. Alonso A, Rojo F & Martinez JL (1999) Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin. Environ Microbiol 1: 421-430.
11. Alonso A, Morales G, Escalante R, Campanario E, Sastre L & Martinez JL (2004) Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology. J Antimicrob Chemoth 53: 432-434.
12. Aminov RI (2009) The role of antibiotics and antibiotic resistance in nature. Environ Microbiol 11: 2970-2988.
13. Andersson DI (2006) The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 9: 461-465.
14. Andersson DI & Hughes D (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8: 260-271.
15. Andersson DI & Levin BR (1999) The biological cost of antibiotic resistance. Curr Opin Microbiol 2: 489-493.
16. Balaban NQ, Merrin J, Chait R, Kowalik L & Leibler S (2004) Bacterial persistence as a phenotypic switch. Science 305: 1622-1625.
17. Balsalobre L & de la Campa AG (2008) Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes. Antimicrob Agents Ch 52: 822-830.
18. Baquero F, Alvarez-Ortega C & Martinez JL (2009) Ecology and evolution of antibiotic resistance. Environ Microbiol Rep 1: 469-476.
19. Barth AL & Pitt TL (1996) The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol 45: 110-119.
20. Bates DM, von Eiff C, McNamara PJ, Peters G, Yeaman MR, Bayer AS & Proctor RA (2003) Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney. J Infect Dis 187: 1654-1661.
21. Beltramini AM, Mukhopadhyay CD & Pancholi V (2009) Modulation of cell wall structure and antimicrobial susceptibility by a Staphylococcus aureus eukaryote-like serine/threonine kinase and phosphatase. Infect Immun 77: 1406-1416.
22. Benveniste R & Davies J (1973) Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. P Natl Acad Sci USA 70: 2276-2280.
23. Bertin P, Hommais F, Krin E, Soutourina O, Tendeng C, Derzelle S & Danchin A (2001) H-NS and H-NS-like proteins in Gram-negative bacteria and their multiple role in the regulation of bacterial metabolism. Biochimie 83: 235-241.
24. Bjorkman J, Nagaev I, Berg OG, Hughes D & Andersson DI (2000) Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287: 1479-1482.
25. Breidenstein EB, Khaira BK, Wiegand I, Overhage J & Hancock RE (2008) Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob Agents Ch 52: 4486-4491.
26. Bryan LE & Van Den Elzen HM (1977) Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob Agents Ch 12: 163-177.
27. Bull JJ, Levin BR, DeRouin T, Walker N & Bloch CA (2002) Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol 2: 35.
28. Burse A, Weingart H & Ullrich MS (2004) NorM, an Erwinia amylovora multidrug efflux pump involved in in vitro competition with other epiphytic bacteria. Appl Environ Microb 70: 693-703.
29. Cano DA, Pucciarelli MG, Martinez-Moya M, Casadesus J & Garcia-del Portillo F (2003) Selection of small-colony variants of Salmonella enterica serovar typhimurium in nonphagocytic eucaryotic cells. Infect Immun 71: 3690-3698.
30. Castaneda-Garcia A, Rodriguez-Rojas A, Guelfo JR & Blazquez J (2009) Glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa. J Bacteriol 191: 6968-6974.
31. Chao MC & Rubin EJ (2010) Letting sleeping dos lie: does dormancy play a role in tuberculosis? Annu Rev Microbiol 64: 293-311.
32. Chenia HY, Pillay B & Pillay D (2006) Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens. J Antimicrob Chemoth 58: 1274-1278.
33. Chico-Calero I, Suarez M, Gonzalez-Zorn B, Scortti M, Slaghuis J, Goebel W & Vazquez-Boland JA (2002) Hpt, a bacterial homolog of the microsomal glucose-6-phosphate translocase, mediates rapid intracellular proliferation in Listeria. P Natl Acad Sci USA 99: 431-436.
34. Clement S, Vaudaux P, Francois P et al. (2005) Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis 192: 1023-1028.
35. Clements MO, Watson SP, Poole RK & Foster SJ (1999) CtaA of Staphylococcus aureus is required for starvation survival, recovery, and cytochrome biosynthesis. J Bacteriol 181: 501-507.
36. Cohen SP, McMurry LM, Hooper DC, Wolfson JS & Levy SB (1989) Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Ch 33: 1318-1325.
37. Collier DN, Hager PW & Phibbs PV Jr (1996) Catabolite repression control in the Pseudomonads. Res Microbiol 147: 551-561.
38. Cowan SW, Schirmer T, Rummel G et al. (1992) Crystal structures explain functional properties of two E. coli porins. Nature 358: 727-733.
39. Darcan C, Ozkanca R & Flint KP (2003) Survival of nonspecific porin-deficient mutants of Escherichia coli in black sea water. Lett Appl Microbiol 37: 380-385.
40. D'Argenio DA, Wu M, Hoffman LR et al. (2007) Growth phenotypes of Pseudomonas aeruginosalasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64: 512-533.
41. Dasgupta A, Datta P, Kundu M & Basu J (2006) The serine/threonine kinase PknB of Mycobacterium tuberculosis phosphorylates PBPA, a penicillin-binding protein required for cell division. Microbiology 152: 493-504.
42. Davies JE (1997) Origins, acquisition and dissemination of antibiotic resistance determinants. Ciba F Symp 207: 15-27.
43. Delcour AH (2009) Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 1794: 808-816.
44. Donat S, Streker K, Schirmeister T et al. (2009) Transcriptome and functional analysis of the eukaryotic-type serine/threonine kinase PknB in Staphylococcus aureus. J Bacteriol 191: 4056-4069.
45. Dotsch A, Becker T, Pommerenke C, Magnowska Z, Jansch L & Haussler S (2009) Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Ch 53: 2522-2531.
46. Doumith M, Ellington MJ, Livermore DM & Woodford N (2009) Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemoth 63: 659-667.
47. Eagle H (1949) The effect of the size of the inoculum and the age of the infection on the curative dose of penicillin in experimental infections with streptococci, pneumococci, and Treponema pallidum. J Exp Med 90: 595-607.
48. Enne VI, Delsol AA, Roe JM & Bennett PM (2006) Evidence of antibiotic resistance gene silencing in Escherichia coli. Antimicrob Agents Ch 50: 3003-3010.
49. Erol I, Jeong KC, Baumler DJ, Vykhodets B, Choi SH & Kaspar CW (2006) H-NS controls metabolism and stress tolerance in Escherichia coli O157:H7 that influence mouse passage. BMC Microbiol 6: 72.
50. Evans K, Passador L, Srikumar R, Tsang E, Nezezon J & Poole K (1998) Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa. J Bacteriol 180: 5443-5447.
51. Fajardo A & Martinez JL (2008) Antibiotics as signals that trigger specific bacterial responses. Curr Opin Microbiol 11: 161-167.
52. Fajardo A, Martinez-Martin N, Mercadillo M et al. (2008) The neglected intrinsic resistome of bacterial pathogens. PLoS One 3: e1619.
53. Fajardo A, Linares JF & Martinez JL (2009) Towards an ecological approach to antibiotics and antibiotic resistance genes. Clin Microbiol Infec 15 (suppl 1): 14-16.
54. Fernandez P, Saint-Joanis B, Barilone N, Jackson M, Gicquel B, Cole ST & Alzari PM (2006) The Ser/Thr protein kinase PknB is essential for sustaining mycobacterial growth. J Bacteriol 188: 7778-7784.
55. Fitoussi F, Cohen R, Brami G, Doit C, Brahimi N, de la Rocque F & Bingen E (1997) Molecular DNA analysis for differentiation of persistence or relapse from recurrence in treatment failure of Streptococcus pyogenes pharyngitis. Eur J Clin Microbiol 16: 233-237.
56. Forst SA & Roberts DL (1994) Signal transduction by the EnvZ-OmpR phosphotransfer system in bacteria. Res Microbiol 145: 363-373.
57. George AM & Levy SB (1983) Gene in the major cotransduction gap of the Escherichia coli K-12 linkage map required for the expression of chromosomal resistance to tetracycline and other antibiotics. J Bacteriol 155: 541-548.
58. Ghosh A, Paul K & Chowdhury R (2006) Role of the histone-like nucleoid structuring protein in colonization, motility, and bile-dependent repression of virulence gene expression in Vibrio cholerae. Infect Immun 74: 3060-3064.
59. Ginsberg AM (2010) Drugs in development for tuberculosis. Drugs 70: 2201-2214.
60. Girgis HS, Hottes AK & Tavazoie S (2009) Genetic architecture of intrinsic antibiotic susceptibility. PLoS One 4: e5629.
61. Gomez MJ & Neyfakh AA (2006) Genes involved in intrinsic antibiotic resistance of Acinetobacter baylyi. Antimicrob Agents Ch 50: 3562-3567.
62. Gomez-Gomez JM, Blazquez J, Baquero F & Martinez JL (1996) Hns mutant unveils the presence of a latent haemolytic activity in Escherichia coli K-12. Mol Microbiol 19: 909-910.
63. Gomez-Gomez JM, Blazquez J, Baquero F & Martinez JL (1997) H-NS and RpoS regulate emergence of Lac Ara+ mutants of Escherichia coli MCS2. J Bacteriol 179: 4620-4622.
64. Gooderham WJ & Hancock RE (2009) Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. FEMS Microbiol Rev 33: 279-294.
65. Gooderham WJ, Gellatly SL, Sanschagrin F et al. (2009) The sensor kinase PhoQ mediates virulence in Pseudomonas aeruginosa. Microbiology 155: 699-711.
66. Govan JR & Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539-574.
67. Govan JR & Nelson JW (1992) Microbiology of lung infection in cystic fibrosis. Brit Med Bull 48: 912-930.
68. Groisman EA (1998) The ins and outs of virulence gene expression: Mg2+ as a regulatory signal. Bioessays 20: 96-101.
69. Groisman EA (2001) The pleiotropic two-component regulatory system PhoP-PhoQ. J Bacteriol 183: 1835-1842.
70. Gruer MJ, Bradbury AJ & Guest JR (1997) Construction and properties of aconitase mutants of Escherichia coli. Microbiology 143: 1837-1846.
71. Haas D (2006) Cost of cell-cell signalling in Pseudomonas aeruginosa: why it can pay to be signal-blind. Nat Rev Microbiol 4: 562; author reply 562.
72. Hall RM & Collis CM (1995) Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination. Mol Microbiol 15: 593-600.
73. Hansen S, Lewis K & Vulic M (2008) Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Ch 52: 2718-2726.
74. Harrison JA, Pickard D, Higgins CF et al. (1994) Role of hns in the virulence phenotype of pathogenic salmonellae. Mol Microbiol 13: 133-140.
75. Heinemann M, Kummel A, Ruinatscha R & Panke S (2005) In silico genome-scale reconstruction and validation of the Staphylococcus aureus metabolic network. Biotechnol Bioeng 92: 850-864.
76. Helling RB & Kukora JS (1971) Nalidixic acid-resistant mutants of Escherichia coli deficient in isocitrate dehydrogenase. J Bacteriol 105: 1224-1226.
77. Henderson TA, Young KD, Denome SA & Elf PK (1997) AmpC and AmpH, proteins related to the class C beta-lactamases, bind penicillin and contribute to the normal morphology of Escherichia coli. J Bacteriol 179: 6112-6121.
78. Hester KL, Lehman J, Najar F et al. (2000) Crc is involved in catabolite repression control of the bkd operons of Pseudomonas putida and Pseudomonas aeruginosa. J Bacteriol 182: 1144-1149.
79. Heurlier K, Denervaud V, Haenni M, Guy L, Krishnapillai V & Haas D (2005) Quorum-sensing-negative (lasR) mutants of Pseudomonas aeruginosa avoid cell lysis and death. J Bacteriol 187: 4875-4883.
80. Heurlier K, Denervaud V & Haas D (2006) Impact of quorum sensing on fitness of Pseudomonas aeruginosa. Int J Med Microbiol 296: 93-102.
81. Hirakawa H, Nishino K, Yamada J, Hirata T & Yamaguchi A (2003) Beta-lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J Antimicrob Chemoth 52: 576-582.
82. Hoffman LR, Kulasekara HD, Emerson J, Houston LS, Burns JL, Ramsey BW & Miller SI (2009) Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J Cyst Fibros 8: 66-70.
83. Hoffman LR, Richardson AR, Houston LS et al. (2010) Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog 6: e1000712.
84. Hogan D & Kolter R (2002) Why are bacteria refractory to antimicrobials? Curr Opin Microbiol 5: 472-477.
85. Hoiby N (1998) Pseudomonas in Cystic Fibrosis: Past, Present, and Future. Cystic Fibrosis Trust, London, UK.
86. Hommais F, Krin E, Laurent-Winter C et al. (2001) Large-scale monitoring of pleiotropic regulation of gene expression by the prokaryotic nucleoid-associated protein, H-NS. Mol Microbiol 40: 20-36.
87. Huang CT, Yu FP, McFeters GA & Stewart PS (1995) Nonuniform spatial patterns of respiratory activity within biofilms during disinfection. Appl Environ Microb 61: 2252-2256.
88. Hunter T (1995) Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80: 225-236.
89. Ingavale S, van Wamel W, Luong TT, Lee CY & Cheung AL (2005) Rat/MgrA, a regulator of autolysis, is a regulator of virulence genes in Staphylococcus aureus. Infect Immun 73: 1423-1431.
90. Jacobsen KA (1910) Mitteilungen über einen variablen Typhusstamm (Bacterium typhi mutabile), sowie über eine eigentümliche hemmende Wirkung des gewöhnlichen agar, verursacht durch autoklavierung. Zentralbl Bakteriol [Orig A] 56: 208-216.
91. Jain V, Kumar M & Chatterji D (2006) ppGpp: stringent response and survival. J Microbiol 44: 1-10.
92. Joseph B, Przybilla K, Stuhler C, Schauer K, Slaghuis J, Fuchs TM & Goebel W (2006) Identification of Listeria monocytogenes genes contributing to intracellular replication by expression profiling and mutant screening. J Bacteriol 188: 556-568.
93. Kallman O, Giske CG, Samuelsen O, Wretlind B, Kalin M & Olsson-Liljequist B (2009) Interplay of efflux, impermeability, and AmpC activity contributes to cefuroxime resistance in clinical, non-ESBL-producing isolates of Escherichia coli. Microb Drug Resist 15: 91-95.
94. Kang CM, Abbott DW, Park ST, Dascher CC, Cantley LC & Husson RN (2005) The Mycobacterium tuberculosis serine/threonine kinases PknA and PknB: substrate identification and regulation of cell shape. Gene Dev 19: 1692-1704.
95. Keren I, Shah D, Spoering A, Kaldalu N & Lewis K (2004) Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186: 8172-8180.
96. Kim W & Surette MG (2003) Swarming populations of Salmonella represent a unique physiological state coupled to multiple mechanisms of antibiotic resistance. Biol Proced Online 5: 189-196.
97. Kim W, Killam T, Sood V & Surette MG (2003) Swarm-cell differentiation in Salmonella enterica serovar typhimurium results in elevated resistance to multiple antibiotics. J Bacteriol 185: 3111-3117.
98. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA & Collins JJ (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797-810.
99. Kohanski MA, Dwyer DJ, Wierzbowski J, Cottarel G & Collins JJ (2008) Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135: 679-690.
100. Kohanski MA, Dwyer DJ & Collins JJ (2010) How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 8: 423-435.
101. Kohler T, van Delden C, Curty LK, Hamzehpour MM & Pechere JC (2001) Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J Bacteriol 183: 5213-5222.
102. Koul A, Arnoult E, Lounis N, Guillemont J & Andries K (2011) The challenge of new drug discovery for tuberculosis. Nature 469: 483-490.
103. Kussell E, Kishony R, Balaban NQ & Leibler S (2005) Bacterial persistence: a model of survival in changing environments. Genetics 169: 1807-1814.
104. Laurent-Winter C, Ngo S, Danchin A & Bertin P (1997) Role of Escherichia coli histone-like nucleoid-structuring protein in bacterial metabolism and stress response - identification of targets by two-dimensional electrophoresis. Eur J Biochem 244: 767-773.
105. Lee EH & Shafer WM (1999) The farAB-encoded efflux pump mediates resistance of gonococci to long-chained antibacterial fatty acids. Mol Microbiol 33: 839-845.
106. Lee EH, Rouquette-Loughlin C, Folster JP & Shafer WM (2003) FarR regulates the farAB-encoded efflux pump of Neisseria gonorrhoeae via an MtrR regulatory mechanism. J Bacteriol 185: 7145-7152.
107. Lee SW, Foley EJ & Epstein JA (1944) Mode of action of penicillin: I. Bacterial growth and penicillin activity-Staphylococcus aureus FDA. J Bacteriol 48: 393-399.
108. Leimeister-Wachter M, Haffner C, Domann E, Goebel W & Chakraborty T (1990) Identification of a gene that positively regulates expression of listeriolysin, the major virulence factor of Listeria monocytogenes. P Natl Acad Sci USA 87: 8336-8340.
109. Levin BR & Rozen DE (2006) Non-inherited antibiotic resistance. Nat Rev Microbiol 4: 556-562.
110. Lewis K (2010) Persister cells. Annu Rev Microbiol 64: 357-372.
111. Li W & Lu CD (2007) Regulation of carbon and nitrogen utilization by CbrAB and NtrBC two-component systems in Pseudomonas aeruginosa. J Bacteriol 189: 5413-5420.
112. Li XZ, Zhang L, McKay GA & Poole K (2003) Role of the acetyltransferase AAC(6')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia. J Antimicrob Chemoth 51: 803-811.
113. Linares JF, Lopez JA, Camafeita E, Albar JP, Rojo F & Martinez JL (2005) Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J Bacteriol 187: 1384-1391.
114. Linares JF, Gustafsson I, Baquero F & Martinez JL (2006) Antibiotics as intermicrobial signaling agents instead of weapons. P Natl Acad Sci USA 103: 19484-19489.
115. Linares JF, Moreno R, Fajardo A, Martinez-Solano L, Escalante R, Rojo F & Martinez JL (2010) The global regulator Crc modulates metabolism, susceptibility to antibiotics and virulence in Pseudomonas aeruginosa. Environ Microbiol 12: 3196-3212.
116. Lindberg F & Normark S (1986) Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria. Rev Infect Dis 8 (suppl 3): S292-S304.
117. Lucchini S, Rowley G, Goldberg MD, Hurd D, Harrison M & Hinton JC (2006) H-NS mediates the silencing of laterally acquired genes in bacteria. PLoS Pathog 2: e81.
118. Luo N, Pereira S, Sahin O, Lin J, Huang S, Michel L & Zhang Q (2005) Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. P Natl Acad Sci USA 102: 541-546.
119. Luong TT, Dunman PM, Murphy E, Projan SJ & Lee CY (2006) Transcription profiling of the mgrA regulon in Staphylococcus aureus. J Bacteriol 188: 1899-1910.
120. Lyczak JB, Cannon CL & Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15: 194-222.
121. Macek B, Gnad F, Soufi B, Kumar C, Olsen JV, Mijakovic I & Mann M (2008) Phosphoproteome analysis of E. coli reveals evolutionary conservation of bacterial Ser/Thr/Tyr phosphorylation. Mol Cell Proteomics 7: 299-307.
122. Macfarlane EL, Kwasnicka A & Hancock RE (2000) Role of Pseudomonas aeruginosa PhoP-PhoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology 146: 2543-2554.
123. MacGregor CH, Wolff JA, Arora SK & Phibbs PV Jr (1991) Cloning of a catabolite repression control (crc) gene from Pseudomonas aeruginosa, expression of the gene in Escherichia coli, and identification of the gene product in Pseudomonas aeruginosa. J Bacteriol 173: 7204-7212.
124. MacGregor CH, Arora SK, Hager PW, Dail MB & Phibbs PV Jr (1996) The nucleotide sequence of the Pseudomonas aeruginosa pyrE-crc-rph region and the purification of the crc gene product. J Bacteriol 178: 5627-5635.
125. Macinga DR & Rather PN (1999) The chromosomal 2'-N-acetyltransferase of Providencia stuartii: physiological functions and genetic regulation. Front Biosci 4: D132-D140.
126. Maggiorani Valecillos A, Rodriguez Palenzuela P & Lopez-Solanilla E (2006) The role of several multidrug resistance systems in Erwinia chrysanthemi pathogenesis. Mol Plant Microbe In 19: 607-613.
127. Martinez JL (2008) Antibiotics and antibiotic resistance genes in natural environments. Science 321: 365-367.
128. Martinez JL & Baquero F (2000) Mutation frequencies and antibiotic resistance. Antimicrob Agents Ch 44: 1771-1777.
129. Martinez JL & Baquero F (2002) Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev 15: 647-679.
130. Martinez JL, Baquero F & Andersson DI (2007) Predicting antibiotic resistance. Nat Rev Microbiol 5: 958-965.
131. Martinez JL, Fajardo A, Garmendia L, Hernandez A, Linares JF, Martinez-Solano L & Sanchez MB (2009a) A global view of antibiotic resistance. FEMS Microbiol Rev 33: 44-65.
132. Martinez JL, Sanchez MB, Martinez-Solano L, Hernandez A, Garmendia L, Fajardo A & Alvarez-Ortega C (2009b) Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev 33: 430-449.
133. Martinez-Solano L, Macia MD, Fajardo A, Oliver A & Martinez JL (2008) Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis 47: 1526-1533.
134. Massova I & Mobashery S (1998) Kinship and diversification of bacterial penicillin-binding proteins and beta-lactamases. Antimicrob Agents Ch 42: 1-17.
135. McCune RM Jr & Tompsett R (1956) Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J Exp Med 104: 737-762.
136. Mc Dermott W (1958) Microbial persistence. Yale J Biol Med 30: 257-291.
137. Mena A, Smith EE, Burns JL, Speert DP, Moskowitz SM, Perez JL & Oliver A (2008) Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J Bacteriol 190: 7910-7917.
138. Meroueh SO, Minasov G, Lee W, Shoichet BK & Mobashery S (2003) Structural aspects for evolution of beta-lactamases from penicillin-binding proteins. J Am Chem Soc 125: 9612-9618.
139. Mizuno T & Mizushima S (1990) Signal transduction and gene regulation through the phosphorylation of two regulatory components: the molecular basis for the osmotic regulation of the porin genes. Mol Microbiol 4: 1077-1082.
140. 2+ concentrations, and is highly interconnected with a wide variety of cellular processes. Biochem J 424: 129-141.
141. Morales G, Linares JF, Beloso A, Albar JP, Martinez JL & Rojo F (2004a) The Pseudomonas putida Crc global regulator controls the expression of genes from several chromosomal catabolic pathways for aromatic compounds. J Bacteriol 186: 1337-1344.
142. Morales G, Wiehlmann L, Gudowius P, van Delden C, Tummler B, Martinez JL & Rojo F (2004b) Structure of Pseudomonas aeruginosa populations analyzed by single nucleotide polymorphism and pulsed-field gel electrophoresis genotyping. J Bacteriol 186: 4228-4237.
143. Moreno R & Rojo F (2008) The target for the Pseudomonas putida Crc global regulator in the benzoate degradation pathway is the BenR transcriptional regulator. J Bacteriol 190: 1539-1545.
144. Moreno R, Ruiz-Manzano A, Yuste L & Rojo F (2007) The Pseudomonas putida Crc global regulator is an RNA binding protein that inhibits translation of the AlkS transcriptional regulator. Mol Microbiol 64: 665-675.
145. Moreno R, Martinez-Gomariz M, Yuste L, Gil C & Rojo F (2009a) The Pseudomonas putida Crc global regulator controls the hierarchical assimilation of amino acids in a complete medium: evidence from proteomic and genomic analyses. Proteomics 9: 2910-2928.
146. Moreno R, Marzi S, Romby P & Rojo F (2009b) The Crc global regulator binds to an unpaired A-rich motif at the Pseudomonas putida alkS mRNA coding sequence and inhibits translation initiation. Nucleic Acids Res 37: 7678-7690.
147. Morosini MI, Ayala JA, Baquero F, Martinez JL & Blazquez J (2000) Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob Agents Ch 44: 3137-3143.
148. Mortimer PG & Piddock LJ (1993) The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli. J Antimicrob Chemoth 32: 195-213.
149. Mulcahy H, Charron-Mazenod L & Lewenza S (2008) Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog 4: e1000213.
150. Muller C, Plesiat P & Jeannot K (2011) A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and beta-lactams in Pseudomonas aeruginosa. Antimicrob Agents Ch 55: 1211-1221.
151. Muller CM, Dobrindt U, Nagy G, Emody L, Uhlin BE & Hacker J (2006) Role of histone-like proteins H-NS and StpA in expression of virulence determinants of uropathogenic Escherichia coli. J Bacteriol 188: 5428-5438.
152. Nasser W, Faelen M, Hugouvieux-Cotte-Pattat N & Reverchon S (2001) Role of the nucleoid-associated protein H-NS in the synthesis of virulence factors in the phytopathogenic bacterium Erwinia chrysanthemi. Mol Plant Microbe In 14: 10-20.
153. Navarre WW, Porwollik S, Wang Y, McClelland M, Rosen H, Libby SJ & Fang FC (2006) Selective silencing of foreign DNA with low GC content by the H-NS protein in Salmonella. Science 313: 236-238.
154. Nikaido H (1998) Multiple antibiotic resistance and efflux. Curr Opin Microbiol 1: 516-523.
155. Nishino K & Yamaguchi A (2004) Role of histone-like protein H-NS in multidrug resistance of Escherichia coli. J Bacteriol 186: 1423-1429.
156. Nishino K, Hayashi-Nishino M & Yamaguchi A (2009) H-NS modulates multidrug resistance of Salmonella enterica serovar Typhimurium by repressing multidrug efflux genes acrEF. Antimicrob Agents Ch 53: 3541-3543.
157. Okamoto K, Gotoh N & Nishino T (2001) Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay. Antimicrob Agents Ch 45: 1964-1971.
158. Olekhnovich IN & Kadner RJ (2007) Role of nucleoid-associated proteins Hha and H-NS in expression of Salmonella enterica activators HilD, HilC, and RtsA required for cell invasion. J Bacteriol 189: 6882-6890.
159. Overhage J, Lewenza S, Marr AK & Hancock RE (2007) Identification of genes involved in swarming motility using a Pseudomonas aeruginosa PAO1 mini-Tn5-lux mutant library. J Bacteriol 189: 2164-2169.
160. Overhage J, Bains M, Brazas MD & Hancock RE (2008) Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J Bacteriol 190: 2671-2679.
161. Palchaudhuri S, Tominna B & Leon MA (1998) H-NS regulates DNA repair in Shigella. J Bacteriol 180: 5260-5262.
162. Park D & Forst S (2006) Co-regulation of motility, exoenzyme and antibiotic production by the EnvZ-OmpR-FlhDC-FliA pathway in Xenorhabdus nematophila. Mol Microbiol 61: 1397-1412.
163. Perkins AE & Nicholson WL (2008) Uncovering new metabolic capabilities of Bacillus subtilis using phenotype profiling of rifampin-resistant rpoB mutants. J Bacteriol 190: 807-814.
164. Pesavento C & Hengge R (2009) Bacterial nucleotide-based second messengers. Curr Opin Microbiol 12: 170-176.
165. Pethe K, Sequeira PC, Agarwalla S et al. (2010) A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nat Commun 1: 1-8.
166. Piddock LJ (2006) Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol 4: 629-636.
167. Pranting M, Negrea A, Rhen M & Andersson DI (2008) Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2. Antimicrob Agents Ch 52: 2734-2741.
168. Proctor RA, van Langevelde P, Kristjansson M, Maslow JN & Arbeit RD (1995) Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis 20: 95-102.
169. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M & Peters G (2006) Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4: 295-305.
170. Rani SA, Pitts B, Beyenal H et al. (2007) Spatial patterns of DNA replication, protein synthesis, and oxygen concentration within bacterial biofilms reveal diverse physiological states. J Bacteriol 189: 4223-4233.
171. Rau MH, Hansen SK, Johansen HK et al. (2010) Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ Microbiol 12: 1643-1658.
172. Reguera JA, Baquero F, Perez-Diaz JC & Martinez JL (1991) Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli. J Antimicrob Chemoth 27: 569-575.
173. Ripio MT, Brehm K, Lara M, Suarez M & Vazquez-Boland JA (1997) Glucose-1-phosphate utilization by Listeria monocytogenes is PrfA dependent and coordinately expressed with virulence factors. J Bacteriol 179: 7174-7180.
174. Rojo F (2010) Carbon catabolite repression in Pseudomonas: optimizing metabolic versatility and interactions with the environment. FEMS Microbiol Rev 34: 658-684.
175. Saier MH Jr, Paulsen IT, Sliwinski MK, Pao SS, Skurray RA & Nikaido H (1998) Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J 12: 265-274.
176. Sanchez MB & Martinez JL (2010) SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia. Antimicrob Agents Ch 54: 580-581.
177. Sanchez MB, Hernandez A, Rodriguez-Martinez JM, Martinez-Martinez L & Martinez JL (2008) Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol 8: 148.
178. Sanchez MB, Hernandez A & Martinez JL (2009) Stenotrophomonas maltophilia drug resistance. Future Microbiol 4: 655-660.
179. Sanchez P, Alonso A & Martinez JL (2002a) Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. Antimicrob Agents Ch 46: 3386-3393.
180. Sanchez P, Linares JF, Ruiz-Diez B, Campanario E, Navas A, Baquero F & Martinez JL (2002b) Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J Antimicrob Chemoth 50: 657-664.
181. Sander P, Springer B, Prammananan T, Sturmfels A, Kappler M, Pletschette M & Bottger EC (2002) Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob Agents Ch 46: 1204-1211.
182. Sandoz KM, Mitzimberg SM & Schuster M (2007) Social cheating in Pseudomonas aeruginosa quorum sensing. P Natl Acad Sci USA 104: 15876-15881.
183. Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103: 211-225.
184. Schurek KN, Marr AK, Taylor PK, Wiegand I, Semenec L, Khaira BK & Hancock RE (2008) Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Ch 52: 4213-4219.
185. Scortti M, Lacharme-Lora L, Wagner M, Chico-Calero I, Losito P & Vazquez-Boland JA (2006) Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro-in vivo paradox. Nat Med 12: 515-517.
186. Seggewiss J, Becker K, Kotte O et al. (2006) Reporter metabolite analysis of transcriptional profiles of a Staphylococcus aureus strain with normal phenotype and its isogenic hemB mutant displaying the small-colony-variant phenotype. J Bacteriol 188: 7765-7777.
187. Shcherbakov D, Akbergenov R, Matt T, Sander P, Andersson DI & Bottger EC (2010) Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in-vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis. Mol Microbiol 77: 830-840.
188. Sheldon AT Jr (2005) Antibiotic resistance: a survival strategy. Clin Lab Sci 18: 170-180.
189. Shin S & Park C (1995) Modulation of flagellar expression in Escherichia coli by acetyl phosphate and the osmoregulator OmpR. J Bacteriol 177: 4696-4702.
190. Shiraishi K, Ogata Y, Hanada K, Kano Y & Ikeda H (2007) Roles of the DNA binding proteins H-NS and StpA in homologous recombination and repair of bleomycin-induced damage in Escherichia coli. Genes Genet Syst 82: 433-439.
191. Silo-Suh L, Suh SJ, Phibbs PV & Ohman DE (2005) Adaptations of Pseudomonas aeruginosa to the cystic fibrosis lung environment can include deregulation of zwf, encoding glucose-6-phosphate dehydrogenase. J Bacteriol 187: 7561-7568.
192. Smith EE, Buckley DG, Wu Z et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. P Natl Acad Sci USA 103: 8487-8492.
193. Smith HW & Huggins MB (1982) Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 128: 307-318.
194. Sonnleitner E, Abdou L & Haas D (2009) Small RNA as global regulator of carbon catabolite repression in Pseudomonas aeruginosa. P Natl Acad Sci USA 106: 21866-21871.
195. Srivatsan A & Wang JD (2008) Control of bacterial transcription, translation and replication by (p)ppGpp. Curr Opin Microbiol 11: 100-105.
196. Sternberg C, Christensen BB, Johansen T, Toftgaard Nielsen A, Andersen JB, Givskov M & Molin S (1999) Distribution of bacterial growth activity in flow-chamber biofilms. Appl Environ Microb 65: 4108-4117.
197. Stickland HG, Davenport PW, Lilley KS, Griffin JL & Welch M (2010) Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa. J Proteome Res 9: 2957-2967.
198. Stock AM, Robinson VL & Goudreau PN (2000) Two-component signal transduction. Annu Rev Biochem 69: 183-215.
199. Stokes HW & Hall RM (1989) A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol Microbiol 3: 1669-1683.
200. Struelens MJ, Schwam V, Deplano A & Baran D (1993) Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. J Clin Microbiol 31: 2320-2326.
201. Suci PA, Mittelman MW, Yu FP & Geesey GG (1994) Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob Agents Ch 38: 2125-2133.
202. Sun X, Ge F, Xiao CL, Yin XF, Ge R, Zhang LH & He QY (2009) Phosphoproteomic analysis reveals the multiple roles of phosphorylation in pathogenic bacterium Streptococcus pneumoniae. J Proteome Res 9: 275-282.
203. Tamae C, Liu A, Kim K et al. (2008) Determination of antibiotic hypersensitivity among 4, 000 single-gene-knockout mutants of Escherichia coli. J Bacteriol 190: 5981-5988.
204. Tamber S, Schwartzman J & Cheung AL (2010) Role of PknB kinase in antibiotic resistance and virulence in community-acquired methicillin-resistant Staphylococcus aureus strain USA300. Infect Immun 78: 3637-3646.
205. Tavankar GR, Mossialos D & Williams HD (2003) Mutation or overexpression of a terminal oxidase leads to a cell division defect and multiple antibiotic sensitivity in Pseudomonas aeruginosa. J Biol Chem 278: 4524-4530.
206. Tingpej P, Smith L, Rose B et al. (2007) Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. J Clin Microbiol 45: 1697-1704.
207. Toleman MA, Bennett PM & Walsh TR (2006) ISCR elements: novel gene-capturing systems of the 21st century? Microbiol Mol Biol R 70: 296-316.
208. Toman K (1981) Bacterial persistence in leprosy. Int J Leprosy 49: 205-217.
209. Truong-Bolduc QC, Zhang X & Hooper DC (2003) Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus. J Bacteriol 185: 3127-3138.
210. Truong-Bolduc QC, Dunman PM, Strahilevitz J, Projan SJ & Hooper DC (2005) MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J Bacteriol 187: 2395-2405.
211. Tuchscherr L, Medina E, Hussain M et al. (2011) Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 3: 129-141.
212. Vesga O, Groeschel MC, Otten MF, Brar DW, Vann JM & Proctor RA (1996) Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis 173: 739-742.
213. Vila J & Martinez JL (2008) Clinical impact of the over-expression of efflux pump in nonfermentative gram-negative bacilli, development of efflux pump inhibitors. Curr Drug Targets 9: 797-807.
214. von Eiff C, Heilmann C, Proctor RA, Woltz C, Peters G & Gotz F (1997) A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol 179: 4706-4712.
215. von Eiff C, McNamara P, Becker K et al. (2006) Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. J Bacteriol 188: 687-693.
216. Waksman SA & Woodruff HB (1940) The soil as a source of microorganisms antagonistic to disease-producing bacteria. J Bacteriol 40: 581-600.
217. Warner DF & Mizrahi V (2006) Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy. Clin Microbiol Rev 19: 558-570.
218. Warner DM, Folster JP, Shafer WM & Jerse AE (2007) Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae. J Infect Dis 196: 1804-1812.
219. Wiedemann B, Pfeifle D, Wiegand I & Janas E (1998) beta-Lactamase induction and cell wall recycling in gram-negative bacteria. Drug Resist Update 1: 223-226.
220. Will WR, Lu J & Frost LS (2004) The role of H-NS in silencing F transfer gene expression during entry into stationary phase. Mol Microbiol 54: 769-782.
221. Williams P & Camara M (2009) Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr Opin Microbiol 12: 182-191.
222. Wolff JA, MacGregor CH, Eisenberg RC & Phibbs PV Jr (1991) Isolation and characterization of catabolite repression control mutants of Pseudomonas aeruginosa PAO. J Bacteriol 173: 4700-4706.
223. Wu J, Long Q & Xie J (2010) (p)ppGpp and drug resistance. J Cell Physiol 224: 300-304.
224. Yeats C, Finn RD & Bateman A (2002) The PASTA domain: a beta-lactam-binding domain. Trends Biochem Sci 27: 438.
225. Yeom J, Imlay JA & Park W (2010) Iron homeostasis affects antibiotic-mediated cell death in Pseudomonas species. J Biol Chem 285: 22689-22695.
226. Yergeau E, Lawrence JR, Waiser MJ, Korber DR & Greer CW (2010) Meta-transcriptomic analysis of the response of river biofilms to pharmaceutical products using anonymous DNA microarrays. Appl Environ Microb 26: 5432-5439.
227. Yeung AT, Torfs EC, Jamshidi F, Bains M, Wiegand I, Hancock RE & Overhage J (2009) Swarming of Pseudomonas aeruginosa is controlled by a broad spectrum of transcriptional regulators, including MetR. J Bacteriol 191: 5592-5602.
228. Yeung AT, Bains M & Hancock RE (2011) The sensor kinase CbrA is a global regulator that modulates metabolism, virulence, and antibiotic resistance in Pseudomonas aeruginosa. J Bacteriol 193: 918-931.
229. Yim G, Wang HH & Davies J (2006) The truth about antibiotics. Int J Med Microbiol 296: 163-170.
230. Yim G, Wang HH & Davies J (2007) Antibiotics as signalling molecules. Philos T R Soc B 362: 1195-1200.
231. Yoneyama H & Nakae T (1993) Mechanism of efficient elimination of protein D2 in outer membrane of imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Ch 37: 2385-2390.
232. Yuste L & Rojo F (2001) Role of the crc gene in catabolic repression of the Pseudomonas putida GPo1 alkane degradation pathway. J Bacteriol 183: 6197-6206.
233. Zhang L & Mah TF (2008) Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J Bacteriol 190: 4447-4452.
234. Zielenski J & Tsui LC (1995) Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 29: 777-807.
235. Zimmermann T, Sorg T, Siehler SY & Gerischer U (2009) Role of Acinetobacter baylyi Crc in catabolite repression of enzymes for aromatic compound catabolism. J Bacteriol 191: 2834-2842.